Bharat Immunologicals (India) Performance

Bharat Immunologicals holds performance score of 21 on a scale of zero to a hundred. The firm shows Beta (market volatility) of 1.6829 which signifies that as market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Bharat Immunologicals will likely underperform.. Although it is essential to pay attention to Bharat Immunologicals historical returns, it is also good to be reasonable about what you can actually do with equity current trading patterns. Macroaxis philosophy in foreseeing future performance of any stock is to look not only at its past charts but also at the business as a whole, including all available fundamental and technical indicators. To evaluate if Bharat Immunologicals Biologicals Corp Ltd expected return of 2.0265 will be sustainable into the future, we have found twenty-one different technical indicators which can help you to check if the expected returns are sustainable. Use Bharat Immunologicals Jensen Alpha, Semi Variance and the relationship between Standard Deviation and Value At Risk to analyze future returns on Bharat Immunologicals.
Investment Horizon     30 Days    Login   to change

Relative Risk vs. Return Landscape

If you would invest  2,740  in Bharat Immunologicals Biologicals Corp Ltd on April 23, 2017 and sell it today you would earn a total of  935.00  from holding Bharat Immunologicals Biologicals Corp Ltd or generate 34.12% return on investment over 30 days. Bharat Immunologicals Biologicals Corp Ltd is generating 2.0265% of daily returns and assumes 6.3599% volatility on return distribution over the 30 days horizon. Simply put, 62% of equities are less volatile than Bharat Immunologicals Biologicals Corp Ltd and 55% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
 Daily Expected Return (%) 
      Risk (%) 
Assuming 30 trading days horizon, Bharat Immunologicals Biologicals Corp Ltd is expected to generate 12.75 times more return on investment than the market. However, the company is 12.75 times more volatile than its market benchmark. It trades about 0.32 of its potential returns per unit of risk. The NYSE is currently generating roughly 0.04 per unit of risk.

Operating Margin

Bharat Immunologicals Operating Margin
Based on recorded statements Bharat Immunologicals Biologicals Corp Ltd has Operating Margin of -5.13%. This is much lower than that of the sector, and significantly lower than that of Operating Margin industry, The Operating Margin for all stocks is over 1000% higher than the company.
A good Operating Margin is required for a company to be able to pay for its fixed costs or pay out its debt which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against firm's competitors.

One Month Efficiency

Bharat Immunologicals Sharpe Ratio = 0.3186
Best
Portfolio
Best
Equity
Good Returns
Average ReturnsBIBCL
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns

Estimated Market Risk

 6.36
  actual daily
 
 38 %
of total potential
  

Expected Return

 2.03
  actual daily
 
 45 %
of total potential
  

Risk-Adjusted Return

 0.32
  actual daily
 
 21 %
of total potential
  
Based on monthly moving average Bharat Immunologicals is performing at about 21% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bharat Immunologicals by adding it to a well-diversified portfolio.